University at Buffalo (UB)
"Incretin Based Therapeutics for the Treatment of CV Risk in Type 2 Diabetes: Insights from the Bench and Bedside"
Sanjay Rajagopalan, MBBS, FACC, FAHA
Melvin Sharoky, MD Endowed Professorship in Medicine
Division Head, Cardiovascular Medicine
University of Maryland, Baltimore
Karen Ruzycki
Email: ruzycki@buffalo.edu